Nucleus is a consumer health startup offering clinical-grade whole-genome DNA analysis to provide real-time, actionable insights into an individual’s health. By analyzing over 800 health conditions, including cancer, heart disease, and Alzheimer’s, Nucleus delivers personalized risk assessments that combine genetic data with lifestyle factors like BMI and cholesterol. Their affordable platform, priced at just $399, is designed to empower individuals to take proactive control of their health. Nucleus aims to revolutionize the healthcare experience with continuous updates, leveraging advances in genomics, AI, and data privacy to offer a comprehensive, evolving health profile.